Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

InMed Pharmaceuticals (INM) Equity Ratio: 2022-2025

Historic Equity Ratio for InMed Pharmaceuticals (INM) over the last 4 years, with Jun 2025 value amounting to 0.86.

  • InMed Pharmaceuticals' Equity Ratio rose 8.13% to 0.87 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.87, marking a year-over-year increase of 8.13%. This contributed to the annual value of 0.86 for FY2025, which is 10.74% up from last year.
  • Per InMed Pharmaceuticals' latest filing, its Equity Ratio stood at 0.86 for FY2025, which was up 10.74% from 0.78 recorded in FY2024.
  • In the past 5 years, InMed Pharmaceuticals' Equity Ratio registered a high of 0.86 during FY2025, and its lowest value of 0.71 during FY2022.
  • In the last 3 years, InMed Pharmaceuticals' Equity Ratio had a median value of 0.86 in 2023 and averaged 0.83.
  • Per our database at Business Quant, InMed Pharmaceuticals' Equity Ratio grew by 20.72% in 2023 and then fell by 9.14% in 2024.
  • InMed Pharmaceuticals' Equity Ratio (MRY) stood at 0.71 in 2022, then grew by 20.72% to 0.86 in 2023, then dropped by 9.14% to 0.78 in 2024, then increased by 10.74% to 0.86 in 2025.
  • Its Equity Ratio stands at 0.86 for FY2025, versus 0.78 for FY2024 and 0.86 for FY2023.